| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |